Answers are grounded in this paper and cite their sources.
A four-drug adjuvant chemotherapy regimen (CONPADRI-I) was utilized in the primary treatment of 18 children with osteogenic sarcoma. All patients had surgical amputation for the primary lesion. The children then received cyclophosphamide, vincristine, melphalan, and adriamycin in defined combinations intermittently over a 72-week period. Of the 18 patients, 10 (55%) remain free of disease 24 months or longer from time of amputation.
No takes yet. Share an insight, caveat, or question.
Sutow et al. (1975) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: